5-amino-1mq nnmt inhibitor obesity (5A1MQ, 5-amino-1-methylquinolinium iodide, inhibitor) · Mechanism, Evidence, FAQ · PEPPUDEX 5-Amino-1MQ (NNMT Inhibitor) – 50

In Canada and most of the European Union, its not approved for medical or cosmetic use and is considered an unregulated compound (Health Canada advisory listing AOD9604 as unauthorized)

Subcutaneous injection, for instance, generally results in a relatively fast absorption and subsequent clearance, leading to the commonly cited 2-3 hour plasma AOD-9604 half life

The Akkermansia species muciniphila has been shown to alter glucose and lipid metabolism as well as intestinal immunity 86 , to strengthen the integrity of the enterocyte monolayer to possibly improve intestinal barrier integrity 87 , and to improve glucose tolerance and reduce visceral adipose tissue inflammation in mice fed an HFD 88

Working with a qualified healthcare provider who understands peptide therapy is strongly recommended for proper dosing, monitoring, and safety

Recommended Frequency: Monthly

The compound must survive the harsh environment of the stomach and be absorbed through the gut wall